SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013305
Filing Date
2020-11-09
Accepted
2020-11-09 13:23:45
Documents
55
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bstc-20200930x10q.htm   iXBRL 10-Q 1285023
2 EX-31.1 bstc-20200930xex31d1.htm EX-31.1 15232
3 EX-31.2 bstc-20200930xex31d2.htm EX-31.2 15019
4 EX-32.1 bstc-20200930xex32d1.htm EX-32.1 8042
  Complete submission text file 0001558370-20-013305.txt   5945195

Data Files

Seq Description Document Type Size
5 EX-101.SCH bstc-20200930.xsd EX-101.SCH 32118
6 EX-101.CAL bstc-20200930_cal.xml EX-101.CAL 39260
7 EX-101.DEF bstc-20200930_def.xml EX-101.DEF 176020
8 EX-101.LAB bstc-20200930_lab.xml EX-101.LAB 399959
9 EX-101.PRE bstc-20200930_pre.xml EX-101.PRE 323084
10 EXTRACTED XBRL INSTANCE DOCUMENT bstc-20200930x10q_htm.xml XML 1072180
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34236 | Film No.: 201296953
SIC: 2834 Pharmaceutical Preparations